Journal
Cell Chemical Biology
Publication Date
1-16-2025
Volume
32
Issue
1
First Page
98
Last Page
110.e7
Document Type
Open Access Publication
DOI
10.1016/j.chembiol.2024.10.013
Rights and Permissions
Rebeck ON, Wallace MJ, Prusa J, Ning J, Evbuomwan EM, Rengarajan S, Habimana-Griffin L, Kwak S, Zahrah D, Tung J, Liao J, Mahmud B, Fishbein SRS, Ramirez Tovar ES, Mehta R, Wang B, Gorelik MG, Helmink BA, Dantas G. A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden. Cell Chem Biol. 2025 Jan 16;32(1):98-110.e7. doi: 10.1016/j.chembiol.2024.10.013. Copyright 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Recommended Citation
Rebeck, Olivia N; Wallace, Miranda J; Prusa, Jerome; Ning, Jie; Evbuomwan, Esse M; Rengarajan, Sunaina; Habimana-Griffin, LeMoyne; Kwak, Suryang; Zahrah, David; Tung, Jason; Liao, James; Mahmud, Bejan; Fishbein, Skye R S; Ramirez Tovar, Erick S; Mehta, Rehan; Wang, Bin; Gorelik, Mark G; Dantas, Gautam; and et al., "A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden." Cell Chemical Biology. 32, 1. 98 - 110.e7. (2025).
https://digitalcommons.wustl.edu/oa_4/6430
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
